Natco Pharma Limited has reported a 11.54 percent increase in net profit at Rs 2.17 billion for the quarter ended December 2017 as compared with Rs 1.95 billion in the corresponding quarter previous year.
However, the revenues declined by 16 percent to Rs 5.74 billion for the quarter under review from Rs 6.85 billion in the year-ago period.
A 32 percent decrease in expenditure at Rs 2.97 billion led by a 50 percent decline in the cost of materials consumed during the quarter helped the company to post profits despite a fall in revenues.
Meanwhile Natco board has declared a second interim dividend of Rs 7 per equity share of a face value of Rs 2 for the year 2017.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app